The potential utility of angiogenesis-related biomarkers, including the sFlt-1/PlGF ratio, for predicting preeclampsia are acknowledged in the latest guideline updates from DGGG (German Society of Obstetrics and Gynecology)[39] and ACOG[40]. This evidence concerns the gene PGF and preeclampsia.